Related references
Note: Only part of the references are listed.The characteristic landscape of lncRNAs classified by RBP-lncRNA interactions across 10 cancers
Qiang Zhang et al.
MOLECULAR BIOSYSTEMS (2017)
The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling
Peng Han et al.
MOLECULAR CANCER (2017)
Down-Regulation of lncRNA-AK001085 and its Influences on the Diagnosis of Ankylosing Spondylitis
Xiang Li et al.
MEDICAL SCIENCE MONITOR (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Adjuvant Endocrine Therapy in Breast Cancer: Evolving Paradigms in Premenopausal Women
Lorenzo Rossi et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)
Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205
Hong-Yan Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Highly expressed lncRNA CCND2-AS1 promotes glioma cell proliferation through Wnt/β-catenin signaling
Hua Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer
X. Xue et al.
ONCOGENE (2016)
Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer
Fei Ma et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer
Shifeng Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Long non-coding RNAs, ASAP1-IT1, FAM215A, and LINC00472, in epithelial ovarian cancer
Yuanyuan Fu et al.
GYNECOLOGIC ONCOLOGY (2016)
Integrated analysis of long non-coding RNA-associated ceRNA network reveals potential lncRNA biomarkers in human lung adenocarcinoma
Jing Sui et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers
Alexandra J. van den Broek et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer
Zhi-yuan Fan et al.
TUMOR BIOLOGY (2016)
Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop
Xiunan Li et al.
TUMOR BIOLOGY (2016)
Long noncoding RNA AFAP1-AS1, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis
Fang-teng Liu et al.
ONCOTARGETS AND THERAPY (2016)
Long Non-Coding RNA (lncRNA) Urothelial Carcinoma-Associated 1 (UCA1) Enhances Tamoxifen Resistance in Breast Cancer Cells via Inhibiting mTOR Signaling Pathway
Chihua Wu et al.
MEDICAL SCIENCE MONITOR (2016)
Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/β-Catenin Pathway
Hongying Liu et al.
PLOS ONE (2016)
Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers
Cigdem Selli et al.
BREAST CANCER RESEARCH (2016)
Basic biology and therapeutic implications of lncRNA
O. Khorkova et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Prognostic value of the lymph node ratio in breast cancer subtypes
Guo-Shiou Liao et al.
AMERICAN JOURNAL OF SURGERY (2015)
The prognostic impact of age in different molecular subtypes of breast cancer
Cornelia Liedtke et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer
Yi Shen et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer
Jun Li et al.
CANCER RESEARCH (2015)
The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer
Andrea Nicolini et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2015)
ESR1 mutations-a mechanism for acquired endocrine resistance in breast cancer
Rinath Jeselsohn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?
Wilbert Zwart et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Mitogen-activated protein kinase phosphatase 1 is involved in tamoxifen resistance in MCF7 cells
Gang Ma et al.
ONCOLOGY REPORTS (2015)
Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer
Liya Liu et al.
OncoTargets and Therapy (2015)
Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer
Yi Shen et al.
ONCOTARGET (2015)
E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter
Junjun Chu et al.
ONCOTARGET (2015)
Breast Cancer: Epidemiology and Etiology
ZiQi Tao et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
Long Noncoding RNA Profiles Reveal Three Molecular Subtypes in Glioma
Rui Li et al.
CNS NEUROSCIENCE & THERAPEUTICS (2014)
The Wnt/β-catenin pathway in ovarian cancer: A review
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2013)
Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer
Zhou Du et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer
A. Ward et al.
ONCOGENE (2013)
Reduced Expression of miR-200 Family Members Contributes to Antiestrogen Resistance in LY2 Human Breast Cancer Cells
Tissa T. Manavalan et al.
PLOS ONE (2013)
Adjuvant Systemic Therapies in Breast Cancer
Leonel F. Hernandez-Aya et al.
SURGICAL CLINICS OF NORTH AMERICA (2013)
miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
Yue-Jun He et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2013)
Tamoxifen Resistance and CYP2D6 Copy Numbers in Breast Cancer Patients
Sahar Motamedi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Role of Wnt/β-catenin Signaling in Drug Resistance of Pancreatic Cancer
Jiujie Cui et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Wnt/β-catenin signalling in prostate cancer
Robert M. Kypta et al.
NATURE REVIEWS UROLOGY (2012)
Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
A. Bergamaschi et al.
ONCOGENE (2012)
Novel Staging System for Predicting Disease-Specific Survival in Patients With Breast Cancer Treated With Surgery As the First Intervention: Time to Modify the Current American Joint Committee on Cancer Staging System
Min Yi et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
MacroRNA underdogs in a microRNA world: Evolutionary, regulatory, and biomedical significance of mammalian long non-protein-coding RNA
Leonard Lipovich et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
M. F. E. Godinho et al.
BRITISH JOURNAL OF CANCER (2010)
Maternally Expressed Gene 3 (MEG3) Noncoding Ribonucleic Acid: Isoform Structure, Expression, and Functions
Xun Zhang et al.
ENDOCRINOLOGY (2010)
mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor a serine 167 phosphorylation
Rachel L. Yamnik et al.
FEBS LETTERS (2010)
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Daniele Merico et al.
PLOS ONE (2010)
Long non-coding RNAs: insights into functions
Tim R. Mercer et al.
NATURE REVIEWS GENETICS (2009)
SeqMap: mapping massive amount of oligonucleotides to the genome
Hui Jiang et al.
BIOINFORMATICS (2008)
MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Tyler E. Miller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Wnt/β-catenin signaling in cancer stemness and malignant behavior
Riccardo Fodde et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
Origins of breast cancer subtypes and therapeutic implications
Andrew H. Sims et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
Wnt/β-catenin signaling in development and disease
Hans Clevers
CELL (2006)
Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells
Danielle Meijer et al.
MOLECULAR CANCER RESEARCH (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
AKT activation predicts outcome in breast cancer patients treated with tamoxifen
T Kirkegaard et al.
JOURNAL OF PATHOLOGY (2005)
Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen
N Shoman et al.
MODERN PATHOLOGY (2005)
Bioconductor: open software development for computational biology and bioinformatics
RC Gentleman et al.
GENOME BIOLOGY (2004)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
β-catenin, a novel prognostic marker for breast cancer:: Its roles in cyclin D1 expression and cancer progression
SY Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Cancer - Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus
M Peifer et al.
SCIENCE (2000)
Share Paper
